ArticleFolia microbiologica2026
Culture-based detection of clinically relevant carbapenemase genes in Gram-negative bacteria from aquatic environments in western Algeria.
Article in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) requires environmental surveillance because aquatic systems can receive resistant bacteria, antimicrobial residues and mobile resistance genes from domestic, agricultural, hospital and industrial sources. This culture-based study investigated culturable Gram-negative bacteria recovered from 12 inland, saline, wetland and coastal aquatic sites in western Algeria between January and April 2023. Bacterial isolates were identified by conventional biochemical methods and 16 S rRNA gene sequencing. Antimicrobial susceptibility was assessed by disk diffusion and selected broth microdilution assays, with colistin interpreted only by minimum inhibitory concentration. Phenotypic screening for extended-spectrum beta-lactamase-like and carbapenemase-associated activity was followed by targeted PCR and Sanger sequencing in selected high-risk isolates. Fifty-four Gram-negative isolates were recovered, including 44 fermenting and 10 non-fermenting isolates. Ten isolates, all fermenting Gram-negative bacteria, fulfilled the multidrug-resistant definition after exclusion of species-related intrinsic resistance. Targeted sequencing confirmed blaOXA-48 in two Escherichia coli isolates and one Cronobacter sakazakii isolate. One Escherichia coli isolate co-harbored blaNDM-1 and blaOXA-48. The colistin-resistant Pseudomonas aeruginosa isolate was negative for mcr-1. These findings provide baseline evidence that selected aquatic environments in western Algeria harbor culturable Gram-negative bacteria carrying clinically important carbapenemase genes. The study should be interpreted as targeted culture-based surveillance rather than a quantitative assessment of the aquatic resistome. These data represent the environmental component of AMR surveillance within a One Health framework and do not establish an epidemiological linkage to human or animal reservoirs.
Indexed as
Identifiers
42895684What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.